A new approach to PET imaging offers a promising way for physicians to promptly identify patients who are at risk for poor ...
Select your location to view local American Lung Association events and news near you.
Researchers from Alliance Medical Ltd. performed a retrospective case series review of oncologic FDG PET-CT scans in patients taking GLP-1 agonists ... which prompted a wider review across our network ...
MedPage Today on MSN
GLP-1s May Throw Off Some Medical Scans
GLP-1 receptor agonists have long half-lives so a patient would need to stop taking it a month before a scan for it to completely eliminate the risk of it influencing the imaging. Gadaleta noted that ...
Researchers have reported that the widespread use of glucagon-like peptide-1 receptor agonists – prescribed for diabetes and ...
June 30, 2006 (San Diego) — False-positive results on positron emission tomography (PET) with computed tomography (CT) scans, which may suggest that there is a malignancy when in fact there is none, ...
The rise of GLP-1s prescribed for weight loss and type 2 diabetes is leading to potentially misleading patterns in cancer scans.
PET-CT combines the functional information gained through PET with the structural details gained by a CT scan, aiding in ...
News-Medical.Net on MSN
New imaging technique boosts survival in prostate cancer patients
A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph ...
ctDNA-MRD testing better predicted outcomes versus PET/CT scans for large B-cell lymphoma, leading to NCCN guideline updates for remission assessment. A minimal measurable residual disease (MRD) ...
For years, prostate cancer specialists hit a wall when prostate-specific antigen (PSA) levels crept up after definitive treatment. The cancer was likely back — but where? And to what extent? Bone plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results